木今
Lv21
130 积分
2024-08-08 加入
-
Whole exome sequencing of six Chinese families with hereditary non-syndromic hearing loss
12天前
已完结
-
Analysis of MYO15A variation in children with DFNB3
13天前
已完结
-
Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trial
16天前
已完结
-
Safety and antitumour activity of cadonilimab, an anti-PD-1/CTLA-4 bispecific antibody, for patients with advanced solid tumours (COMPASSION-03): a multicentre, open-label, phase 1b/2 trial
17天前
已完结
-
Intrafamilial phenotypic variability in TBC1D24-TLDc homozygous pathogenic variant-related developmental and epileptic encephalopathy
26天前
已完结
-
Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial
1个月前
已完结
-
Investigation of GALNS variants and genotype–phenotype correlations in a large cohort of patients with mucopolysaccharidosis type IVA
1个月前
已完结
-
Novel human pathological mutations. Gene symbol: GAA. Disease: glycogen storage disease 2
1个月前
已完结
-
LBA2 POD1UM-303/InterAACT 2: Phase III study of retifanlimab with carboplatin-paclitaxel (c-p) in patients (Pts) with inoperable locally recurrent or metastatic squamous cell carcinoma of the anal canal (SCAC) not previously treated with systemic chemotherapy (Chemo)
1个月前
已关闭
-
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer
1个月前
已完结